T Lymphocytes, Cultured, Autologous, Genetically-modified [EXT] - N0000193548

Pharmacologic Code	N0000193548
Pharmacologic Name	T Lymphocytes, Cultured, Autologous, Genetically-modified
Pharmacologic Uses	CD19-directed genetically modified autologous T-cells
Pharmacologic Concept	Terminology Extensions for Classification - [EXT]
Pharmacologic Concept Description	A local MED-RT extension primarily with chemical classification concepts requested by FDA SPL for eventual addition to NLM MeSH, beneath the "Terminology Extensions for Classification [EXT]" concept, mapped to MeSH hierarchy concepts if possible.

The table contains 3 products whose active ingredient are classified under the same pharmacologic class T Lymphocytes, Cultured, Autologous, Genetically-modified [EXT].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	0078-0846	Kymriah	Non-Proprietary Name: Tisagenlecleucel	Injection, Suspension	Intravenous	Novartis Pharmaceuticals Corporation	ACTIVE
	0078-0958	Kymriah	Non-Proprietary Name: Tisagenlecleucel	Injection, Suspension	Intravenous	Novartis Pharmaceuticals Corporation	ACTIVE
	71287-119	Yescarta	Non-Proprietary Name: Axicabtagene Ciloleucel	Suspension	Intravenous	Kite Pharma, Inc.	ACTIVE